The Unexpected Heart Hero: How ​the Natural Medicine Colchicine is Reshaping Cardiovascular Risk Reduction

​​Stephen W. Parcell, ND ABAAHP

For decades, we’ve waged war on heart disease, primarily focusing on cholesterol. While statins have been revolutionary, a persistent “residual risk” for cardiovascular events remained, often linked to a silent, insidious culprit: inflammation. But what if an​ old ​plant-derived ​ drug, primarily known for treating gout, ​could tame this inflammatory storm in your arteries?

Enter colchicine, the surprising “heart hero” that’s making waves in cardiovascular research. ​This plant extract has been used in Naturopathic medicine for decades. Colchicine is an alkaloid that comes from plants in the genus Colchicum, most notably the autumn crocus (Colchicum autumnale). It can also be found in the gl​ory lily (Gloriosa superba). Recent clinical trials are shining a spotlight on its remarkable potential to reduce heart disease risk, going beyond traditional lipid-lowering strategies.

Let’s dive into the exciting benefits colchicine has demonstrated:

1. The Big Picture: Fewer Heart Attacks and Strokes

Perhaps the most compelling evidence comes from studies showing colchicine can directly reduce major adverse cardiovascular events.

• • The COLCOT trial demonstrated that a low daily dose of colchicine (0.5 mg) significantly lowered the risk of a composite of cardiovascular death, cardiac arrest, MI, stroke, and urgent revascularization in patients who recently suffered a heart attack.
  • The LoDoCo and LoDoCo2 trials further solidified this, showing similar significant reductions in heart-related events for patients with stable or chronic coronary artery disease.
  • Even for those with Type 2 Diabetes post-MI, a sub-analysis of COLCOT revealed colchicine’s protective effects, significantly reducing cardiovascular events.
  • Long-term follow-up of the Australian COPS trial showed that even after colchicine was discontinued, patients continued to experience a significant reduction in major cardiovascular events at two years.

2. Fortifying Your Arteries: Plaque Stabilization

Atherosclerosis isn’t just about plaques forming; it’s about them becoming unstable and rupturing, leading to clots that cause heart attacks or strokes. Colchicine appears to make these plaques more resilient.

• The COLOCT trial, using advanced imaging techniques (Optical Coherence Tomography), found that colchicine treatment notably increased the thickness of the fibrous cap covering coronary plaques. A thicker cap makes plaques less likely to rupture.
• This study also observed a reduction in lipid content and inflammatory cells within the plaques, contributing to greater stability.

3. Calming the Storm: Anti-Inflammatory Power

At its core, colchicine is an anti-inflammatory drug, and this is crucial for heart health.

• Multiple studies, including COLCOT and COLOCT, showed that colchicine treatment led to significant reductions in inflammatory markers like high-sensitivity C-reactive protein (hsCRP) and Interleukin-6 (IL-6). These markers are well-known indicators of ongoing inflammation that contributes to plaque progression and instability.

4. A Clearer Path: Preventing Blockages After Stents

For diabetic patients, a common complication after having a bare-metal stent placed is restenosis—the re-narrowing of the artery. Colchicine offers a solution here too.

• A dedicated study found that colchicine therapy post-PCI with bare-metal stents in diabetic patients reduced neointimal hyperplasia (excessive tissue growth within the stent) and, consequently, lowered rates of in-stent restenosis.

The Science Behind the Shield

How does this ancient medicine achieve such modern feats? Colchicine works by interfering with inflammation at a cellular level. It inhibits microtubule polymerization, a process essential for the movement and function of immune cells. Think of it as disrupting the communication lines for inflammation, slowing the infiltration of inflammatory cells, suppressing inflammatory signaling pathways (such as NF-κB), and blocking the activation of critical inflammatory complexes.

Is Colchicine Right for You?

The growing body of evidence strongly supports colchicine’s role in the comprehensive management of atherosclerotic cardiovascular disease. It offers a unique approach by directly targeting the inflammatory component of heart disease, complementing the benefits of lipid-lowering therapies like statins.

While generally well-tolerated at low doses, like any drug, it has potential side effects and may not be suitable for everyone. If you have coronary artery disease or are at high risk, discuss these findings with your cardiologist. They can determine if colchicine, in conjunction with your current treatment plan, could be a beneficial addition to reduce your cardiovascular risk further.

If you’d like to discuss starting ​Colchicine and have a comprehensive, targeted, and personalized cardiovascular visit, please call my office at 303-​884​-7557.